课题基金 / 基金详情

Life history-guided drug discovery from venomous marine snails

Life history-guided drug discovery from venomous marine snails
以生活史为指导的有毒海洋蜗牛药物发现
批准号:
10361532
负责人:
BALDOMERO M OLIVERA
金额:
$29.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2023-02-28

项目摘要

项目成果

BALDOMERO M OLIVERA的其他基金

相似基金

相关文献

中文摘要
翻译
总结
英文摘要
SUMMARY Venomous marine snails in the superfamily Conoidea capture their prey by injecting a complex mixture of ribosomally-synthesized peptides that undergo extensive post-translational modification. These conopeptides target receptors and ion channels in the prey's nervous, endocrine and sensory system with remarkable potency and specificity. Owing to their diversity and target selectivity, conopeptides have become invaluable tools for ion channel research and as therapeutics. The rationale of using cone snail venoms as a source for drug discovery is that homologs of many molecular targets expressed in the prey of cone snails are also found in humans where they are implicated in diverse physiological disorders, including inflammation, epilepsy, neuropathic pain and diabetes. Several recent discoveries made in my group now demonstrate that each of the ~700 cone snail species produces a distinct set of conopeptides that are finely tuned for a specific set of receptors in its prey. Thus, the central hypothesis of this grant is that drug discovery can be maximized by sequencing and characterizing the venom composition of many species from diverse lineages of cone snails, including those that induce diverse physiological endpoints in their prey. This is a highly innovative approach because it takes full advantage of the unique strategies that evolved in these animals for prey capture: species that induce rapid paralysis in their prey are likely to express toxins that target the neuromuscular junction and pain circuits whereas those that induce hypoactivity and sedation are more likely to have evolved toxins that target the sensory and endocrine system. Our preliminary research has already identified several unique drug leads for the treatment of diabetes, a disease that has been recognized as a global epidemic, and pain, a leading cause for the current opioid epidemic. This proposal will enable us to efficiently scale these promising initial efforts. The specific aims of this project are (Aim 1) to undertake a large-scale, evolution-guided collection and next-generation sequencing effort of venoms from all ~50 major lineages of cone snails, (Aim 2) to develop an innovative computational pipeline, the Taxonomer Venoms Module, to analyze these large sequencing datasets, and (Aim 3) to use a tiered, data-driven selection process to pharmacologically characterize the most promising novel toxins from these large datasets. We will also seek to identify and characterize conopeptide biosynthetic pathways. Doing so will improve synthetic and recombinant means for production of conopeptides for functional studies. The expected outcomes are significant. We will provide a computational pipeline for drug discovery that will lead to the identification of many novel classes of conopeptides and their biosynthetic enzymes that will fuel scientific discovery and drug development activities for decades to come.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/ijms19113418
发表时间: 2018-10-31
期刊: International journal of molecular sciences
影响因子: 5.6
作者: [O'Brien H, Kanemura S, Okumura M, Baskin RP, Bandyopadhyay PK, Olivera BM, Ellgaard L, Inaba K, Safavi-Hemami H]
通讯作者: Safavi-Hemami H
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
  • 批准号:
    10592438
  • 项目类别:
  • 资助金额:
    $57.45万
  • 财政年份:
    2022
  • 负责人:
    BALDOMERO M OLIVERA
  • 依托单位:
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
  • 批准号:
    10346236
  • 项目类别:
  • 资助金额:
    $57.32万
  • 财政年份:
    2022
  • 负责人:
    BALDOMERO M OLIVERA
  • 依托单位:
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
  • 批准号:
    10798547
  • 项目类别:
  • 资助金额:
    $15.34万
  • 财政年份:
    2022
  • 负责人:
    BALDOMERO M OLIVERA
  • 依托单位:
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
  • 批准号:
    10810172
  • 项目类别:
  • 资助金额:
    $1.08万
  • 财政年份:
    2022
  • 负责人:
    BALDOMERO M OLIVERA
  • 依托单位:
海外基金